Siemens Aktiengesellschaft · XETR:SIE
Siemens Aktiengesellschaft — Siemens — Investor Day (September 2009)
35 slides from Siemens Aktiengesellschaft's investor day presentation, Sep 29, 2009
Slide 1: Siemens Healthcare: Leading the Industry
Siemens Healthcare Leading the Industry Hermann Requardt CEO Healthcare Sector Capital Market Day Siemens Healthcare London, September 29, 2009 © Siemens AG 2009. All rights reserved.
Slide 2: Safe Harbour Statement
Safe Harbour Statement This document contains forward-looking statements and information – that is, statements related to future, not past, events. These statements may be identified by words such as “expects,” “looks forward to,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,”
Slide 3: Leading the Healthcare Industry
Leading the Healthcare Industry Principles Key takeaways Increase We have the best portfolio of products, services and solutions in the market place TRANSPARENCY We have unparalleled understanding of the needs and resources of our customers Enforce We are managing our value added profile to AC
Slide 4: Siemens Healthcare – A global Healthcare powerhouse
Siemens Healthcare – A global Healthcare powerhouse Key data FY 2008: Revenue: €11.2bn Underlying margin: 15.6% Employees: ~ 48,900 R&D: ~ €1.1bn Workflow & Division revenues Imaging & IT Solutions Diagnostics €6.8bn €1.5bn €3.2bn © Siemens AG 2009. All rights reserved. Page 4 Sept. 29, 2009
Slide 5: We are the leader in Imaging & IT
We are the leader in Imaging & IT Healthcare IT Angio Computed Magnetic Molecular Ultrasound and X-Ray Tomography Resonance Imaging Leading in new equipment market share Innovation Largest installed base leader Best in profitability © Siemens AG 2009. All rights reserved. Page 5 Sept. 29, 2009
Slide 6: IT – The key for achieving healthcare efficiency
IT – The key for achieving healthcare efficiency "Why wouldn't we want to put that on an electronic medical record that will reduce error rates, reduce our long-term cost of health- care, and create jobs right now?" U.S. President, Barack Obama, 2009 "As Japanese healthcare service faces severe chal
Slide 7: Accelerating our IT performance
Accelerating our IT performance Workflow-oriented IT solutions ... ... focused as never before What's new? Hospital information System (HIS) Selected approaches for key regions and Soarian essential customer requirements Soarian i.s.h.med MedSuite Sales oriented approach with global and local pa
Slide 8: Leadership in Diagnostics
Leadership in Diagnostics Laboratory automation Laboratory Information System Chemistry Immuno- Point-of- Hemostasis/ Micro- Molecular assay Care Hematology biology Leader in hospital laboratories Largest installed base © Siemens AG 2009. All rights reserved. Page 8 Sept. 29, 2009 Capital Market
Slide 9: Workflow & Solutions leading the trend towards disease orientation
Workflow & Solutions leading the trend towards disease orientation Solution and Consulting Services Women's Surgery Oncology Urology Audiology Health Growth in customer solutions and services Driving new Standards of Care solutions © Siemens AG 2009. All rights reserved. Page 9 Sept. 29, 2009 Ca
Slide 10: U.S. market – growth in diagnostics offset by weakness in imaging
U.S. market – growth in diagnostics market off-set by weakness in imaging U.S. imaging equipment market1) U.S. diagnostics market2) Growth Y-o-Y US$bn Growth Y-o-Y US$bn 8% 4% 15 15 8% 7% 11.6 ~12.1 4% -3% -13% 10.1 10.8 -16% 10 9.3 10 6.2 6.4 6.2 5.5 ~4.6 5 5 0 0 FY FY FY FY FY FY FY FY FY FY 2005
Slide 11: Medium-term growth trend is intact
Medium-term growth trend is intact Sector market – by Division €bn (revenue) Medium-term growth drivers: +2% 62 5% • Growing and aging population 58 • New solutions to improve lab efficiency ~ 5-6% Diagnostics +4% 26 • Disease orientation, new applications 24 • Growth in oncology and minimal Workflo
Slide 12: Our solutions matched to specific customer's needs
Our solutions matched to specific customer's needs We know our … and offer most customer’s profile … appropriate solutions Public Authorities Regional Healthcare consulting C-Level / Administration Integrated Healthcare projects Enterprise Healthcare IT solutions Clinical Segment Disease Cardi
Slide 13: Siemens Healthcare as partner of choice
Siemens Healthcare as partner of choice Customer insight Customer appreciation Customer retention We know and understand our customers Our customers are convinced by our products Our customers are committed to us Superior market trans- Delivering the best Best-in-class retention rate parency –
Slide 14: Resources match global growth opportunities
Resources match global growth opportunities Change of global market structure Americas Europe, CIS, Asia, Australia Africa 45% 44% 41% 41% 40% 35% 20% 19% 15% Market Revenue Employees Market Revenue Employees Market Revenue Employees Regional market, revenue, employees in FY 2008 incl. SISL (India)
Slide 15: Broader footprint in emerging markets, consolidation in established markets
Broader footprint in emerging markets, consolidation in established markets 1992 2002 2003 2003 1995 2002 2005 Conso- Conso- lidated lidated Iselin Solna Wuxi Suzhou Shanghai Seoul 2004 Conso- 2001 2008 lidated Conso- Issaquah lidated Dresden Pohang 2004 2007 2009 Acquisition 1998 Conso- Kyungju Con
Slide 16: Products suited for all customer segments
Products suited for all customer segments Leading Cutting-edge technology solutions medical institutes Medium- and Wide range of diagnostic and therapy solutions large-size urban hospitals County-level Basic healthcare solutions hospitals and township health centers © Siemens AG 2009. All rights res
Slide 17: Growing our emerging markets presence
Growing our emerging markets presence Healthcare revenue growth1) in emerging markets China +17% p.a. FY 2007 FY 2009E Brazil +11% p.a. India +11% p.a. FY 2007 FY 2009E FY 2007 FY 2009E 1) Year-on-year on a comparable basis, i.e. excluding currency translation and portfolio effects © Siemens AG 2009
Slide 18: Successful SMART products for local markets
Successful SMART® products for local markets Unit growth1) Example: SOMATOM Emotion 16 +9% p.a. Development in China CT Production in China Product management in China 70% exported worldwide FY FY FY 2008 2009E 2010E Unit growth1) Example: MAGNETOM ESSENZA +84% p.a. Development in China MR
Slide 19: We optimize the entire value chain in a multi-domestic approach
We optimize the entire value chain in a multi-domestic approach Product Design / Manu- Sourcing Service Management R&D facturing Understand Tap into local Low cost Leverage low Global ser- local clinical innovation sourcing cost position vice network needs potential (24/7) (follow- Lever
Slide 20: We continuously drive down our costs
We continuously drive down our costs MR example: Savings through localization and product cost reduction Localization of value chain in China Project Design / Manu- Worldwide Sourcing management R&D facturing service support 60% 50% 85% 85% 100% Share in China, in % of labor involved; sourcing in %
Slide 21: Leadership in process innovation
Leadership in process innovation 'Best Factory' Award for Angiography Business Industrial Excellence Award 'The Best Factory' Early integration of key customers, sales, engineering, suppliers, production and service in development teams Maximum transparency by comprehensive IT systems and inform
Slide 22: Innovation drives our success
Innovation drives our success Development of MR new equipment market share First open MR 0.2 T First 1.5T Open First MAGNETOM with a super- system with low operation cost Bore (70 cm) system for obese No. 1 conductive 0.35T magnet for clinical and claustro- applications phobic patients First MR syst
Slide 23: Our innovation is driven by customer needs
Our innovation is driven by customer needs Clinical utility Open bore MR for obese Congestive heart Lowest dose CT Breast cancer test & claustroph. patients failure test (BNP) (HER-2/neu) Workflow efficiency Integrated diagnostic Increased productivity Lab automation Workflow-enabling IT systems wit
Slide 24: Flash speed CT at lowest dose
Flash speed CT at lowest dose Customer needs SOMATOM Definition Flash >50% market share in this segment Increased throughput Lower cost Complete chest pain diagnosis Broad 80% dose saving compared to standard chest application pain protocol range No motion artifacts 25% contrast media saving ©
Slide 25: Intelligent analytics for a more efficient laboratory workflow
Intelligent analytics for a more efficient laboratory workflow Customer needs Dimension Vista® The only next-generation technology that intelligently integrates capabilities of multiple systems into one High quality test results in specified time period Use less labor Dimension Vista® 3000T Dimensio
Slide 26: Leading the industry in service excellence
Leading the industry in service excellence Leading in remote service in Imaging Service excellence in Diagnostics Real-time monitoring unique in the industry First in industry with worldwide remote service Æ Reduced site visits by 8% since 2006 Real-time monitoring of more than 450 More than
Slide 27: Intelligent allocation of R&D resources
Intelligent allocation of R&D resources Invest in Main source of competitive advantage growing & profitable 65% of total R&D invest allocated to new product businesses development and breakthrough technologies Leveraging software and hardware product platforms Foster platform synergies 15% o
Slide 28: Biomarkers will revolutionize healthcare
Biomarkers will revolutionize healthcare Imaging biomarkers Market opportunities Oncology Angiogenesis, hypoxia… Companion diagnostic solutions, therapy monitoring Market potential: ~€0.8bn CNS2) (Alzheimer) Novel, proprietary PET1) biomarkers for Early detection molecular imaging Defini
Slide 29: Our portfolio is aligned with long term trends in medicine
Our portfolio is aligned with long term trends in medicine Understand the patient's Understand the Access state-of-the-art disease patient‘s biology data bases Diagnosis of a disorder Genetic pre-disposition Assessment of similar cases (e.g. infection, cancer, …) Patient metabolism / Struc
Slide 30: Committed to deliver on our financial targets
Committed to deliver on our financial targets Leading the industry Focus and Efficiency Best product portfolio Capital efficiency as top priority Unparalleled understanding of customer needs Aggressive cost management Multi-domestic approach to value added structure Focus on cash generat
Slide 31: Reconciliation and Definitions for Non-GAAP Measures (I)
Reconciliation and Definitions for Non-GAAP Measures (I) To supplement Siemens’ Consolidated Financial Statements presented in accordance with International Financial Reporting Standards, or IFRS, Siemens presents the following supplemental financial measures: New orders; Adjusted or organic gro
Slide 32: Reconciliation and Definitions for Non-GAAP Measures (II)
Reconciliation and Definitions for Non-GAAP Measures (II) Adjusted or organic growth rates of Revenue and new orders In its financial reports, Siemens presents, on a worldwide basis and for each Sector and Cross-Sector Business, the percentage change from period to period in Revenue and new orders a
Slide 33: Reconciliation and Definitions for Non-GAAP Measures (III)
Reconciliation and Definitions for Non-GAAP Measures (III) ROCE at the Siemens group level, on a continuing operations basis Siemens also presents group ROCE on a continuing operations basis. For this purpose, the numerator is Income from continuing operations and the denominator is CE, less Assets
Slide 34: Reconciliation and Definitions for Non-GAAP Measures (IV)
Reconciliation and Definitions for Non-GAAP Measures (IV) Adjusted industrial net debt Siemens defines adjusted industrial net debt as net debt less (1) SFS debt excluding SFS internally purchased receivables; less (2) 50% of the nominal amount of our hybrid bond; plus (3) the funded status of pensi
Slide 35: Siemens investor relations contact data
Siemens investor relations contact data Mariel von Drathen +49-89-636-33780 Munich Office +49-89-636-32474 US Office +1-408-464-2004 Internet: http://www.siemens.com/investorrelations Email: investorrelations@siemens.com Fax: +49-89-636-32830 © Siemens AG 2009. All rights reserved. Page 35 Sept. 29,